Skip to main content

Shannon Timothy M's Form 4 filing

Rallybio CorpRLYB · filed Aug 4, 2021

Accession no.
0000899243-21-031633
Filed
Aug 4, 2021
Trade date
Jul 28-Aug 2, 2021
Filing delay
7 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $1.00M. It was filed 7 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shannon Timothy MCIK 0001207114Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 28, 2021Common StockJOtherAcquired+2,332,789–F1–2,332,789Indirect
Aug 2, 2021Common StockPPurchaseAcquired+76,923$13.00+$999,9992,409,712Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 28, 2021Common StockJOtherDisposed−282,044–F1–0Indirect
Jul 28, 2021Common StockJOtherDisposed−1,372,990–F1–0Indirect
Jul 28, 2021Common StockJOtherDisposed−677,755–F1–0Indirect
Jul 28, 2021Common StockAGrant or awardAcquired+13,440$0.00$013,440Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the "Preferred Units") reported herein were preferred units of Rallybio Holdings, LLC. The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the "Plan of Liquidation"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation.

Referenced by the price of 1 transaction in Table I and 3 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)